Valsartan 160mg + Hydrochlorothiazide 12.5mg Tablets

Valsartan 160mg + Hydrochlorothiazide 12.5mg combines an angiotensin-receptor blocker with a thiazide diuretic for high blood pressure. It is used when complementary blood-vessel and fluid-balance effects are needed for better pressure control.
Take in the morning to reduce night-time urination, with or without food. Rise slowly if light-headed. Blood pressure, kidney function and electrolytes help assess the response, particularly after initiation or dose changes.
Valsartan blocks angiotensin II-mediated vessel tightening. Hydrochlorothiazide increases sodium and water excretion through the kidneys, reducing circulating volume and blood pressure.
Dizziness, increased urination, low blood pressure and changes in sodium or potassium can occur. Muscle weakness, palpitations, severe thirst or reduced urine output require assessment.
Pregnancy, significant dehydration and severe kidney dysfunction are important risks. Hydrochlorothiazide can raise uric acid and worsen gout. Lithium, NSAIDs and potassium-altering medicines can interact; the two ingredients do not reliably cancel each other's electrolyte effects.
Provides complementary antihypertensive effects in one tablet when a single mechanism is insufficient.
The diuretic component can increase urination; morning use generally reduces sleep disruption.
Yes. Valsartan can raise potassium, whereas hydrochlorothiazide can lower it, so the net effect must be measured rather than assumed.
The thiazide component can increase uric acid and provoke a gout flare in susceptible people.
A modest diuretic effect is expected. Very low urine output, faintness or marked dehydration is different and needs assessment.
Improved readings usually reflect the treatment effect; ongoing therapy is commonly needed to maintain control.
Thiazide diuretic: a medicine that increases renal salt and water removal. Electrolyte: a charged mineral such as sodium or potassium. Uric acid: a substance that can form crystals in gout; AR: Valsartan 160mg + Hydrochlorothiazide 12.5mg أقراص; FR: Valsartan 160mg + Hydrochlorothiazide 12.5mg comprimés; PT: Valsartan 160mg + Hydrochlorothiazide 12.5mg comprimidos; ES: Valsartan 160mg + Hydrochlorothiazide 12.5mg comprimidos; RU: Valsartan 160mg + Hydrochlorothiazide 12.5mg таблетки; ID: Valsartan 160mg + Hydrochlorothiazide 12.5mg tablet; VI: Valsartan 160mg + Hydrochlorothiazide 12.5mg viên nén; MS: Valsartan 160mg + Hydrochlorothiazide 12.5mg tablet; TL: Valsartan 160mg + Hydrochlorothiazide 12.5mg tableta; ZH-SG: Valsartan 160mg + Hydrochlorothiazide 12.5mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Valsartan 160mg + Hydrochlorothiazide 12.5mg Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Valsartan 160mg + Hydrochlorothiazide 12.5mg Tablets